2.要約四半期連結財務諸表及び主な注記
(1)要約四半期連結純損益計算書
| | | |
| | | (単位:百万円) |
| 前第2四半期連結累計期間 (自 2018年4月1日 至 2018年9月30日) | | 当第2四半期連結累計期間 (自 2019年4月1日 至 2019年9月30日) |
売上収益 | 647,096 | | 650,470 |
売上原価 | △143,539 | | △138,872 |
売上総利益 | 503,557 | | 511,597 |
| | | |
販売費及び一般管理費 | △231,530 | | △226,067 |
研究開発費 | △99,566 | | △104,974 |
無形資産償却費 | △17,668 | | △11,200 |
持分法による投資損益 | △602 | | △1,405 |
その他の収益 | 4,697 | | 7,248 |
その他の費用 | △32,045 | | △13,004 |
営業利益 | 126,842 | | 162,196 |
| | | |
金融収益 | 2,106 | | 1,336 |
金融費用 | △650 | | △1,949 |
税引前四半期利益 | 128,298 | | 161,584 |
法人所得税費用 | △24,432 | | △33,056 |
四半期利益 | 103,867 | | 128,527 |
| | | |
四半期利益の帰属 | | | |
親会社の所有者 | 103,867 | | 128,527 |
| | | |
1株当たり四半期利益 | | | |
基本的1株当たり四半期利益(円) | 53.20 | | 68.16 |
希薄化後1株当たり四半期利益(円) | 53.14 | | 68.10 |
E0092045030アステラス製薬株式会社Astellas Pharma Inc.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2019-04-012019-09-30Q22020-03-312018-04-012018-09-302019-03-311falsefalsefalse450302019-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302019-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember450302019-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302019-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302019-09-30jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302019-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302019-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember450302019-09-30jpigp_cor:RetainedEarningsIFRSMember450302019-09-30jpigp_cor:TreasurySharesIFRSMember450302019-09-30jpigp_cor:CapitalSurplusIFRSMember450302019-09-30jpigp_cor:ShareCapitalIFRSMember450302019-04-012019-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302019-04-012019-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember450302019-04-012019-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302019-04-012019-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302019-04-012019-09-30jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302019-04-012019-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302019-04-012019-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember450302019-04-012019-09-30jpigp_cor:RetainedEarningsIFRSMember450302019-04-012019-09-30jpigp_cor:TreasurySharesIFRSMember450302019-04-012019-09-30jpigp_cor:CapitalSurplusIFRSMember450302019-04-012019-09-30jpigp_cor:ShareCapitalIFRSMember450302019-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302019-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450302019-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302019-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302019-03-31jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302019-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302019-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember450302019-03-31jpigp_cor:RetainedEarningsIFRSMember450302019-03-31jpigp_cor:TreasurySharesIFRSMember450302019-03-31jpigp_cor:CapitalSurplusIFRSMember450302019-03-31jpigp_cor:ShareCapitalIFRSMember450302018-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302018-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember450302018-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302018-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302018-09-30jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302018-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302018-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember450302018-09-30jpigp_cor:RetainedEarningsIFRSMember450302018-09-30jpigp_cor:TreasurySharesIFRSMember450302018-09-30jpigp_cor:CapitalSurplusIFRSMember450302018-09-30jpigp_cor:ShareCapitalIFRSMember450302018-04-012018-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302018-04-012018-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember450302018-04-012018-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302018-04-012018-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302018-04-012018-09-30jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302018-04-012018-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302018-04-012018-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember450302018-04-012018-09-30jpigp_cor:RetainedEarningsIFRSMember450302018-04-012018-09-30jpigp_cor:TreasurySharesIFRSMember450302018-04-012018-09-30jpigp_cor:CapitalSurplusIFRSMember450302018-04-012018-09-30jpigp_cor:ShareCapitalIFRSMember450302018-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302018-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450302018-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302018-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302018-03-31jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302018-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302018-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember450302018-03-31jpigp_cor:RetainedEarningsIFRSMember450302018-03-31jpigp_cor:TreasurySharesIFRSMember450302018-03-31jpigp_cor:CapitalSurplusIFRSMember450302018-03-31jpigp_cor:ShareCapitalIFRSMember450302018-03-31450302019-10-31450302019-09-30450302018-09-30450302018-04-012018-09-30450302019-03-31450302019-04-012019-09-30iso4217:JPYxbrli:sharesxbrli:pureiso4217:JPY